Catalyst Wire Dossier Catalyst Wire Dossier

Relistor (methylnaltrexone bromide)

methylnaltrexone bromide · Salix Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Relistor (methylnaltrexone bromide), covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation [Phase 4]

See pricing